 MELBOURNE, Australia, Jan. 25, 2021 GLOBE NEWSWIRE -- Genetic Technologies Limited ASX: GTG; NASDAQ: GENE the Company, a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced registered direct offering of 1,250,000 American Depositary Shares ADSs, each representing six hundred 600 of the Companys ordinary shares, at a purchase price of 5.25 per ADS for gross proceeds of approximately 6.56 million. 